Racial and ethnic differences in the risk of dementia diagnosis under hypothetical blood pressure–lowering interventions: The Multi‐Ethnic Study of Atherosclerosis
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.13894 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von L Paloma Rojas-Saunero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Atherosclerosis, Blood Pressure, Dementia, Hypertension. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIA NIH HHS, National Center for Advancing Translational Sciences (NCATS).
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Substantial racial and ethnic disparities in hypertension and dementia exist in the United States. We evaluated the effect of maintaining systolic blood pressure (SBP) below clinical thresholds on dementia incidence. METHODS We included 6806 Multi‐Ethnic Study of Atherosclerosis participants (44 to 84 years old). We implemented the parametric g‐formula to simulate the hypothetical interventions to reduce SBP below 120 and 140 mmHg over time, accounting for time‐varying confounding. We estimated risk ratios (RRs) and risk differences for dementia incidence at 19 years. RESULTS The RRs (95% confidence intervals [CIs]) comparing an intervention reducing SBP below 120 mmHg to no intervention were 0.93 (0.87 to 0.99) for total sample, 0.95 (0.88 to 1.02) for White, 0.90 (0.79 to 1.02) for Black, 0.90 (0.78 to 1.05) for Latino, and 1.16 (0.83 to 1.55) for Chinese American participants. Results for lowering SBP below 140 mmHg and with death as competing event were attenuated. DISCUSSION The reduction of SBP below 120 mmHg over time has modest effects on reducing dementia incidence. More work is needed to understand the heterogeneity across racial and ethnic groups. Highlights There is a potential beneficial effect in lowering SBP to reduce the risk of dementia, which may vary by race and ethnicity. The percentage of participants who would need intervention on blood pressure to meet clinical thresholds is greater for Black and Latino communities. Results are sensitive to the way that death is specified in the research question and analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA.
- Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
- Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
ORCID-Profile: L Paloma Rojas-Saunero, Marcia Pescador Jimenez
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- National Center for Advancing Translational Sciences (NCATS)
- National Heart, Lung, and Blood Institute
- National Institute on Aging
Zitieren
APA
Rojas-Saunero, L. P., Hughes, T. M., Mayeda, E. R., & Jimenez, M. P. (2024). Racial and ethnic differences in the risk of dementia diagnosis under hypothetical blood pressure–lowering interventions: The Multi‐Ethnic Study of Atherosclerosis. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13894
Vancouver
Rojas-Saunero LP, Hughes TM, Mayeda ER, Jimenez MP. Racial and ethnic differences in the risk of dementia diagnosis under hypothetical blood pressure–lowering interventions: The Multi‐Ethnic Study of Atherosclerosis. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13894
BibTeX
@article{RojasSaunero2024,
author = {Rojas-Saunero, L Paloma and Hughes, Timothy M and Mayeda, Elizabeth Rose and Jimenez, Marcia Pescador},
title = {Racial and ethnic differences in the risk of dementia diagnosis under hypothetical blood pressure–lowering interventions: The Multi‐Ethnic Study of Atherosclerosis},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.13894}
}
EUVIMED